Effects of vonoprazan on gastric PH and clinical course after gastric ESD: A retrospective and prospective study
-
Published:2020-12
Issue:
Volume:60
Page:27-30
-
ISSN:2049-0801
-
Container-title:Annals of Medicine and Surgery
-
language:en
-
Short-container-title:Annals of Medicine and Surgery
Author:
Suto Daisuke,
Yoshida MasashiORCID,
Otake Takaaki,
Ichiishi Eiichiro,
Sato Kiichi,
Murata Kazumoto,
Ebinuma Hirotoshi,
Odaira Hironori,
Suzuki Yutaka,
Kohgo Yutaka
Subject
General Medicine,Surgery
Reference27 articles.
1. Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects—a randomized open-label cross-over study;Sakurai;Aliment. Pharmacol. Ther.,2015
2. Vonoprazan: first global approval;Garnock-Jones;Drugs,2015
3. 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases;Hori;J. Pharmacol. Exp. Therapeut.,2010
4. Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date;Sugano;Therap Adv Gastroenterol,2018
5. A comparative study on the modes of action of TAK-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands;Matsukawa;Biochem. Pharmacol.,2011
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献